Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01779050
Title Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine

Her2-receptor negative breast cancer




Cyclophosphamide + Epirubicin


Cyclophosphamide + Epirubicin + Fluorouracil

Carboplatin + Docetaxel

Cyclophosphamide + Docetaxel

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
*Shaded cells indicate that there was no data available from for the field